Aziyo Biologics Inc.

NASDAQ: AZYO · Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM

Aziyo Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Net Income
-53.95M -32.9M -24.83M
Depreciation & Amortization
3.45M 3.73M 3.73M
Stock-Based Compensation
7.89M 3.65M 3.54M
Other Working Capital
n/a 2.13M -552K
Other Non-Cash Items
n/a -1.63M 2.77M
Deferred Income Tax
n/a n/a -3.03M
Change in Working Capital
n/a 5.71M 2.38M
Operating Cash Flow
-22.66M -21.43M -15.45M
Capital Expenditures
n/a -540K -369K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
-474K n/a n/a
Investing Cash Flow
-474K -540K -369K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
19.09M 8.54M 6.71M
Financial Cash Flow
17.09M 8.54M 6.71M
Net Cash Flow
-6.04M -13.44M -9.1M
Free Cash Flow
-22.66M -21.97M -15.81M